Chinese pharmaceutical company North China Pharmaceutical has announced the completion of a public offering of ten million short-term bonds to raise CNY1bn ($146.93m).
Priced at CNY100 ($14.69) each, the bonds are due 3 April 2018 and carry a rate of 5.3%.
Go deeper with GlobalData
Arena Pharmaceuticals has announced an underwritten public offering of common stock shares to raise $150m.
The US-based biopharmaceutical company plans to use the funds towards the clinical and pre-clinical development of its drug candidates.
Enterome Bioscience and Nestle’s subsidiary Nestle Health Science have announced the formation of a joint venture named Microbiome Diagnostics Partners (MDP).
See Also:
The JV company will be engaged in the discovery, development and commercialisation of diagnostics in multiple disease areas.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataEnterome is a drug development company based in France, while Nestle Health Science is a US-based health science company.
